1. Home
  2. NMRA vs IBEX Comparison

NMRA vs IBEX Comparison

Compare NMRA & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • IBEX
  • Stock Information
  • Founded
  • NMRA 2019
  • IBEX 2017
  • Country
  • NMRA United States
  • IBEX United States
  • Employees
  • NMRA N/A
  • IBEX N/A
  • Industry
  • NMRA
  • IBEX EDP Services
  • Sector
  • NMRA
  • IBEX Technology
  • Exchange
  • NMRA Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • NMRA 287.6M
  • IBEX 267.7M
  • IPO Year
  • NMRA 2023
  • IBEX 2020
  • Fundamental
  • Price
  • NMRA $1.18
  • IBEX $25.08
  • Analyst Decision
  • NMRA Buy
  • IBEX Buy
  • Analyst Count
  • NMRA 8
  • IBEX 2
  • Target Price
  • NMRA $10.14
  • IBEX $25.00
  • AVG Volume (30 Days)
  • NMRA 1.4M
  • IBEX 256.1K
  • Earning Date
  • NMRA 03-03-2025
  • IBEX 05-08-2025
  • Dividend Yield
  • NMRA N/A
  • IBEX N/A
  • EPS Growth
  • NMRA N/A
  • IBEX 37.48
  • EPS
  • NMRA N/A
  • IBEX 2.13
  • Revenue
  • NMRA N/A
  • IBEX $521,725,000.00
  • Revenue This Year
  • NMRA N/A
  • IBEX $6.47
  • Revenue Next Year
  • NMRA N/A
  • IBEX $4.29
  • P/E Ratio
  • NMRA N/A
  • IBEX $11.77
  • Revenue Growth
  • NMRA N/A
  • IBEX 1.66
  • 52 Week Low
  • NMRA $1.16
  • IBEX $13.00
  • 52 Week High
  • NMRA $17.19
  • IBEX $27.83
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 28.48
  • IBEX 53.04
  • Support Level
  • NMRA $1.26
  • IBEX $23.82
  • Resistance Level
  • NMRA $1.48
  • IBEX $25.59
  • Average True Range (ATR)
  • NMRA 0.13
  • IBEX 0.90
  • MACD
  • NMRA 0.08
  • IBEX -0.23
  • Stochastic Oscillator
  • NMRA 10.99
  • IBEX 38.81

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: